Evidence map›Paper›PMID 30717138›Full record

ReviewViruses2019

Crosstalk between Autophagy and Type I Interferon Responses in Innate Antiviral Immunity.

Yu Tian, Ming-Li Wang, Jun Zhao

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yu TianDepartment of Microbiology, Anhui Medical University, Hefei 230032, China. tianyu8464@gmail.com.
Ming-Li WangDepartment of Microbiology, Anhui Medical University, Hefei 230032, China. microbio@ahmu.edu.cn.
Jun ZhaoDepartment of Microbiology, Anhui Medical University, Hefei 230032, China. zhaojun5101@gmail.com.
Anhui Medical University · CN

Funding

2017 Wuhu Science and Technology Plan Project 2017yf01National key research project 2017YFD0500906Natural Science Fund of Anhui Province 1808085MC75Scientific research activities of postdoctoral researchers in Anhui 2017B194
6 · The paper itself

Abstract

Autophagy exhibits dual effects during viral infections, promoting the clearance of viral components and activating the immune system to produce antiviral cytokines. However, some viruses impair immune defenses by collaborating with autophagy. Mounting evidence suggests that the interaction between autophagy and innate immunity is critical to understanding the contradictory roles of autophagy. Type I interferon (IFN-I) is a crucial antiviral factor, and studies have indicated that autophagy affects IFN-I responses by regulating IFN-I and its receptors expression. Similarly, IFN-I and interferon-stimulated gene (ISG) products can harness autophagy to regulate antiviral immunity. Crosstalk between autophagy and IFN-I responses could be a vital aspect of the molecular mechanisms involving autophagy in innate antiviral immunity. This review briefly summarizes the approaches by which autophagy regulates antiviral IFN-I responses and highlights the recent advances on the mechanisms by which IFN-I and ISG products employ autophagy against viruses.

Indexed as

Host-Pathogen InteractionsImmunity, InnateAutophagyGene Expression RegulationHumansInterferon-alphaInterferon-betaInterferon Type ISignal TransductionVirus DiseasesInterferon-alphaInterferon-betaInterferon Type Iantiviral immunityautophagytype I interferon

Identifiers

PMID30717138
PMCPMC6409909
OpenAlexW2912714148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.